chartexchange

PROF
Profound Medical Corp. Common Stock
stockNASDAQ

At CloseNov 19, 2026 3:59:51 PM EST
6.65USD-3.763%(-0.26)103,854
After-hoursNov 19, 2026 4:39:30 PM EST
6.59USD-0.902%(-0.06)
Loading…
Loading…
241.74M
Healthcare
Medical Devices
HQ
Mississauga, ON, Canada
Previous Close
$6.91
Beta
1.39
52-Week High
$8.95 2026-01-13
52-Week Low
$4.80 2026-03-09
SMA 50
$6.34
SMA 200
$6.64
Avg. Vol 10D
152,585
Avg. Vol 30D
200,316
Avg. Vol 90D
183,380
Relative Vol
0.52
35.51M
0.9800%
1,500,000
700
Feb 9, 2015 · 1-for-80 (reverse)
PROF Profile

an inside out approach to prostate ablation profound medical is a canadian medical device company that has developed a unique and minimally invasive procedure to ablate the prostate gland in prostate cancer patients. profound's novel technology combines real-time mr imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. it provides a highly precise treatment tailored to patient-specific anatomy and pathology. this method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery. the potential of this technology is currently being demonstrated in clinical trials. for more information, visit profoundmedical.com

PROF Performance
PeriodPriceDateChangeBeta
1W7.422026-11-13-11.05%0.184
1M5.922026-10-20+11.49%0.641
3M6.652026-08-20-0.75%0.780
6M6.922026-05-20-4.62%0.779
1Y5.882025-11-20+12.34%1.390
2Y7.692024-11-20-14.17%—
5Y12.182021-11-19-45.81%1.003
PROF Stock Summary

Profound Medical Corp. Common Stock (NASDAQ:PROF) stock price today is $6.60, and today's volume is 103,854. PROF is down 4.486% today. The 30 day average volume is 200,316. PROF market cap is $241.74M with 36.63M shares outstanding.